HEMBRAN COMBINATION PRODUCT SYRUP

Mechanism of action

Folic acid is biochemically inactive until it is converted into active forms, primarily tetrahydrofolic acid and methyltetrahydrofolate, by the enzyme dihydrofolate reductase (DHFR). These active forms are essential for maintaining normal erythropoiesis, synthesizing nucleic acids, interconverting amino acids, and generating formate. They participate in critical one-carbon transfer reactions necessary for DNA synthesis and methylation processes. Folic acid, in conjunction with vitamin B12, helps normalize elevated homocysteine levels by facilitating its remethylation to methionine, a process that is crucial for various metabolic pathways.

Pharmacodynamics

Folic acid is an essential cofactor for enzymes involved in nucleic acid synthesis and amino acid metabolism. It is particularly significant in preventing megaloblastic anemia, which arises from impaired DNA synthesis due to folate deficiency. The synthesis of thymidylate, necessary for DNA formation, is directly influenced by folate availability. Folic acid's role is especially crucial during periods of rapid cellular division, and it has protective effects against certain cancer developments. As humans cannot synthesize folic acid endogenously, adequate dietary intake is essential for maintaining normal physiological functions.

Pharmacokinetics

Folic acid is absorbed in the small intestine and is then converted into its active forms within the body. The bioavailability of folic acid is influenced by factors such as food composition and the presence of certain gastrointestinal conditions. Once absorbed, it is transported in the bloodstream, mainly as 5-methyltetrahydrofolate. The distribution of folate occurs within various tissues, with significant

Adverse effects

• Allergic reactions
• Gastrointestinal disturbances
• Skin rash
• Altered sleep patterns

Interactions

• Anticonvulsants may reduce the effectiveness of folic acid
• Methotrexate may interfere with folic acid metabolism
• Trimethoprim-sulfamethoxazole can enhance the effects of folic acid deficiency

Precautions

• Monitor for signs of anemia in patients with malabsorption syndromes
• Use cautiously in patients with a history of hypersensitivity to folic acid
• Assess for vitamin B12 deficiency before initiating treatment, as folic acid can mask symptoms

Pregnancy

Folic acid is essential during pregnancy to prevent neural tube defects and support fetal development. Supplementation is recommended before conception and during the first trimester.

Breast-feeding

Folic acid passes into breast milk, and adequate maternal intake is important to ensure sufficient levels for the nursing infant.

Storage

Store in a cool, dry place away from light. Keep out of reach of children.

Formulations

• Tablets
• Oral solutions
• Injectable forms

Indications

• Iron deficiency anemia
• Vitamin B12 deficiency anemia
• Folate deficiency anemia
• Anemia of chronic disease
• Anemia related to malnutrition

Dosage

Children: Refer to

Adults: Refer to the specific product or BNF for exact dosing guidelines, as hematinic doses vary based on the type and severity of anemia.

Mechanism of action

Hematinitics work by supplying essential nutrients necessary for the synthesis of hemoglobin and red blood cells. For instance, iron is a crucial component of hemoglobin, while vitamin B12 and folate are vital for DNA synthesis in red blood cell precursors. The absorption and utilization of these nutrients stimulate erythropoietin production from the kidneys, enhancing red blood cell production in the bone marrow.

Pharmacodynamics

Hematinitics increase the availability of substrates required for hemoglobin synthesis and red blood cell formation. Iron supplementation leads to an increase in serum ferritin and transferrin saturation, which reflects improved iron stores and oxygen-carrying capacity. Vitamin B12 and folate are involved in critical metabolic pathways, including the conversion of homocysteine to methionine, which is essential for DNA synthesis and cell division.

Pharmacokinetics

The pharmacokinetics of hematinics vary based on the specific agent. Iron is absorbed primarily in the duodenum, with its bioavailability affected by dietary factors and the presence of other medications. Vitamin B12 is absorbed in the ileum through a specific transport mechanism that requires intrinsic factor. Folate is absorbed in the proximal jejunum. Distribution varies, with iron predominantly stored in the liver, spleen, and bone marrow, while vitamin B12 is stored in the liver and folate is distributed throughout body tissues. Excretion routes also differ, with excess iron mainly excreted via the gastrointestinal tract, while vitamin B12 and folate are excreted in urine.

Adverse effects

• Nausea
• Constipation
• Diarrhea
• Abdominal pain
• Allergic reactions
• Iron overload
• Gastrointestinal discomfort

Interactions

• Antacids may reduce the absorption of hematinics
• Certain antibiotics (e.g., tetracyclines, fluoroquinolones) may have reduced efficacy when taken with hematinics
• Vitamin C can enhance the absorption of iron
• Foods high in calcium may interfere with iron absorption

Precautions

• Monitor for signs of gastrointestinal bleeding
• Caution in patients with a history of peptic ulcer disease
• Use with caution in patients with liver disease
• Regular monitoring of iron levels is recommended to prevent overload

Pregnancy

Iron is often recommended during pregnancy to prevent and treat iron deficiency anemia, but high doses should be avoided unless prescribed.

Breast-feeding

Iron supplementation is generally considered safe during breastfeeding, but it should be taken under medical supervision.

Storage

Store in a cool, dry place away from direct sunlight. Keep out of reach of children.

Formulations

• Oral tablets
• Liquid preparations
• Intravenous formulations

Dosage

Children: Refer to specific active ingredient dosing guidelines.

Adults: Refer to specific active ingredient dosing guidelines.

Mechanism of action

The mechanism of action for a syrup formulation depends on its active ingredient. Generally, the active components in syrup formulations can act through various pathways, including receptor modulation, enzyme inhibition, or alteration of physiological processes. For instance, if the syrup contains an antihistamine, it may block H1 histamine receptors, thereby reducing allergic responses.

Pharmacodynamics

Pharmacodynamics refers to the effects of the drug on the body and how it exerts its therapeutic effects. For syrup formulations, this can involve the onset of action, peak effect, and duration of action, which vary depending on the active ingredient. For instance, if the syrup contains an analgesic, the pharmacodynamics would include pain relief mechanisms and the time frame in which relief is achieved.

Pharmacokinetics

Pharmacokinetics involves the absorption, distribution, metabolism, and excretion (ADME) of the drug. Syrups are typically well absorbed from the gastrointestinal tract due to their liquid form, allowing for faster onset of action compared to solid dosage forms. The metabolism and elimination pathways depend on the specific active ingredient, with some being metabolized in the liver and others excreted unchanged by the kidneys.

Pregnancy

It is important to assess the benefit versus risk when considering the use of this drug in pregnancy, as safety data may be limited.

Breast-feeding

Caution is advised when using this medication while breastfeeding, as it may be excreted in breast milk and affect the infant.

Storage

Store in a cool, dry place, away from direct sunlight and out of reach of children.

Mechanism of action

Folic acid, as it is biochemically inactive, is converted to tetrahydrofolic acid and methyltetrahydrofolate by dihydrofolate reductase (DHFR). These folic acid congeners are transported across cells by receptor-mediated endocytosis where they are needed to maintain normal erythropoiesis, synthesize purine and thymidylate nucleic acids, interconvert amino acids, methylate tRNA, and generate and use formate. Using vitamin B12 as a cofactor, folic acid can normalize high homocysteine levels by remethylation of homocysteine to methionine via methionine synthetase. Folic acid, after conversion to tetrahydrofolic acid, is necessary for normal erythropoiesis, synthesis of purine and thymidylates, metabolism of amino acids such as glycine and methionine, and the metabolism of histidine. The principal biochemical function of folates is the mediation of one-carbon transfer reactions. 5-Methyltetrahydrofolate donates a methyl group to homocystine, in the conversion of homocystine to L-methionine. ... 5,10-Methyltetrahydrofolate is regenerated from tetrahydrofolate via the enzyme serine hydroxymethyltransferase, a reaction, which in addition to producing 5,10-methyltetrahydrofolate, yields glycine. ... 5,10-methyltetrahydrofolate, supplies the one carbon group for the methylation of deoxyuridylic acid to form the DNA precursor thymidylic acid. This reaction is catalyzed by thymidylate synthase and the folate product of the reaction is dihydrofolate. Dihydrofolate is converted to tetrahydrofolate via the enzyme dihydrofolate reductase ...

Pharmacodynamics

Folic acid is a water-soluble B-complex vitamin found in foods such as liver, kidney, yeast, and leafy, green vegetables. Also known as folate or Vitamin B9, folic acid is an essential cofactor for enzymes involved in DNA and RNA synthesis. More specifically, folic acid is required by the body for the synthesis of purines, pyrimidines, and methionine before incorporation into DNA or protein. Folic acid is the precursor of tetrahydrofolic acid, which is involved as a cofactor for transformylation reactions in the biosynthesis of purines and thymidylates of nucleic acids. Impairment of thymidylate synthesis in patients with folic acid deficiency is thought to account for the defective deoxyribonucleic acid (DNA) synthesis that leads to megaloblast formation and megaloblastic and macrocytic anemias. Folic acid is particularly important during phases of rapid cell division, such as infancy, pregnancy, and erythropoiesis, and plays a protective factor in the development of cancer. As humans are unable to synthesize folic acid endogenously, diet and supplementation is necessary to prevent deficiencies. In order to function properly within the body, folic acid must first be reduced by the enzyme dihydrofolate reductase (DHFR) into the cofactors dihydrofolate (DHF) and tetrahydrofolate (THF). This important pathway, which is required for de novo synthesis of nucleic acids and amino acids, is disrupted by anti-metabolite therapies such as [DB00563] as they function as DHFR inhibitors to prevent DNA synthesis in rapidly dividing cells, and therefore prevent the formation of DHF and THF. In general, folate serum levels below 5 ng/mL indicate folate deficiency, and levels below 2 ng/mL usually result in megaloblastic anemia.